<DOC>
	<DOCNO>NCT00003456</DOCNO>
	<brief_summary>RATIONALE : Antineoplastons naturally-occurring substance may also make laboratory . Antineoplastons may inhibit growth cancer cell . PURPOSE : This phase II trial study effectiveness antineoplaston therapy treat patient glioblastoma multiforme .</brief_summary>
	<brief_title>Antineoplaston Therapy Treating Patients With Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : - Determine objective response rate escalate dos antineoplastons A10 AS2-1 patient glioblastoma multiforme . - Assess tolerance side effect regimen patient . OUTLINE : Patients receive gradually escalate dos intravenous antineoplaston A10 antineoplaston AS2-1 6 time daily maximum tolerate dose reach . Treatment continue least 2 month absence unacceptable toxicity disease progression . Patients achieve complete response ( CR ) continue treatment additional 8 month CR . Tumors measure 1 month , every 1-2 month 2 year , every 3 month 1 year , every 4 month 1 year , every 6 month 1 year , annually thereafter . PROJECTED ACCRUAL : Not specify</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm glioblastoma multiforme Tumor subtotally resect biopsied Radiologic evidence residual recurrent tumor gadoliniumenhanced MRI , CT scan , positronemission tomography No brain stem tumor PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : More 4 month Hematopoietic : WBC least 1,500/mm^3 Platelet count least 50,000/mm^3 Hemoglobin least 10 g/dL Hepatic : No hepatic failure Bilirubin great 2.5 mg/dL SGOT SGPT great 5 time upper limit normal Renal : Creatinine great 2.5 mg/dL No history renal condition would contraindicate high dosage sodium Cardiovascular : No uncontrolled hypertension Other : Not pregnant nursing PRIOR CONCURRENT THERAPY : Biologic therapy : No prior immunotherapy No concurrent immunomodulatory agent Chemotherapy : No prior chemotherapy No concurrent antineoplastic agent Endocrine therapy : Concurrent corticosteroid cerebral edema allow Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics Recovered prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>